4-Chloro-3-nitrotoluene | CAS:89-60-1

We serve 4-Chloro-3-nitrotoluene CAS:89-60-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Chloro-3-nitrotoluene

Chemical Name:4-Chloro-3-nitrotoluene
CAS.NO:89-60-1
Synonyms:4-Chloro-3-nitrotoluene
1-Chloro-4-methyl-2-nitrobenzene
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 264.8±20.0 °C at 760 mmHg
Melting Point 7 °C(lit.)
Molecular Formula C7H6ClNO2
Molecular Weight 171.581
Flash Point 113.9±21.8 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.570
 
Specification:
Appearance:Light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4-Chloro-3-nitrotoluene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Chloro-4-methyl-2-nitrobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-3-nitrotoluene Use and application,1-Chloro-4-methyl-2-nitrobenzene technical grade,usp/ep/jp grade.


Related News: By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.6-Amino-5-bromoquinoxaline manufacturer As one of the world’s largest API producers and exporters, China’s chemical API production and operating income show steady growth.4-phenylbutan-2-amine supplier Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.3-FLUOROPHENYL ISOTHIOCYANATE vendor Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.Those were the questions dominating Chinese social media after the state-run Xinhua news agency reported Friday that the Shanghai Institute of Materia Medica and the Wuhan Institute of Virology had discovered that the Shuanghuanglian oral liquid — a popular combined herbal remedy commonly used to relieve some symptoms such as fever, cough, and sore throat — could be used to “inhibit” the deadly virus.